Live News EARNINGS H impact Jun 30, 2026, 11:13 AM UTC

Market-Moving News for June 30th

AVAV: 31% | AeroVironment shares are trading higher after the company reported better-than-expected Q4 financial results. GMAB: 8% | Genmab shares are trading higher after the company announced topline results from the Phase 3 EPCORE DLBCL-4 trial. The trial met its primary objective. CNXC: -25% | Concentrix shares are trading lower after the company reported worse-than-expected Q2 financial results and issued Q3 guidance below estimates. Also, the company cut its FY26 guidance below estimates.

AVAV CNXC GMAB

SQUAWKNEWS 2 updates Updated Jun 30, 2026, 12:33 PM UTC

Story updates

11:36:53 AM UTC

SQUAWKNEWS

Concentrix shares are trading lower after the company reported worse-than-expected Q2 financial results and issued Q3 guidance below estimates. Also, the company cut its FY26 guidance below estimates.

12:33:12 PM UTC

SQUAWKNEWS

Genmab shares are trading higher after the company announced topline results from the Phase 3 EPCORE DLBCL-4 trial. The trial met its primary objective.

AVAV: 31% | AeroVironment shares are trading higher after the company reported better-than-expected Q4 financial results.

GMAB: 8% | Genmab shares are trading higher after the company announced topline results from the Phase 3 EPCORE DLBCL-4 trial.

The trial met its primary objective.

CNXC: -25% | Concentrix shares are trading lower after the company reported worse-than-expected Q2 financial results and issued Q3 guidance below estimates.

Also, the company cut its FY26 guidance below estimates.